JACKSON SQUARE CAPITAL, LLC - AIMMUNE THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 158 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
JACKSON SQUARE CAPITAL, LLC ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$35,000
-96.1%
2,394
-91.0%
0.03%
-94.7%
Q4 2019$891,000–26,620–0.51%–
 Download
Other shareholders

There were no reported owners of AIMMUNE THERAPEUTICS INC in Q4 2019.

NameSharesValueWeighting ↓
View complete list of AIMMUNE THERAPEUTICS INC shareholders